Allstar Health Brands, Inc. (ALST)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Allstar Health Brands, Inc. (ALST). Allstar Health Brands, Inc. focuses on providing select medicines, nutritional supplements, and over-the-counter remedies in the Americas. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Allstar Health Brands, Inc. (ALST) Healthcare & Pipeline Overview
Allstar Health Brands, Inc. operates in the specialty healthcare sector, focusing on medicines, nutritional supplements, and over-the-counter remedies within the Americas. The company leverages the Tapout brand through a licensing agreement and a partnership with WWE to market nutraceutical products, positioning itself in the health and wellness market.
Investment Thesis
Allstar Health Brands, Inc. presents a speculative investment opportunity within the specialty healthcare sector. The company's partnership with WWE and the Tapout license for nutraceutical products provide potential avenues for revenue growth. However, the company's small market capitalization and OTC listing introduce significant risks. Investors should carefully consider the company's financial performance, competitive landscape, and regulatory environment before making investment decisions. The company's ability to effectively market and distribute its products, particularly the Tapout line, will be critical to its long-term success. The negative P/E ratio of -0.17 indicates that the company is currently not profitable, requiring careful monitoring of its financial performance and path to profitability.
Based on FMP financials and quantitative analysis
Key Highlights
- Allstar Health Brands, Inc. operates in the specialty healthcare products sector, focusing on select medicines, nutritional supplements, and over-the-counter remedies.
- The company holds the Tapout license to sell globally branded nutraceutical products, including pain relief sprays and wipes.
- Allstar Health Brands, Inc. has a partnership with World Wide Entertainment (WWE) to market and sell their line of Tapout nutraceutical products.
- The company was founded in 1997 and is headquartered in Toronto, Canada.
- Allstar Health Brands, Inc. has a market capitalization of $0.00B and a P/E ratio of -0.17.
Competitors & Peers
Strengths
- Tapout brand license provides a recognizable brand in the nutraceutical market.
- Partnership with WWE offers a unique marketing and distribution channel.
- Focus on specialty healthcare products allows for targeted product development.
- Established presence in the Americas market.
Weaknesses
- Small market capitalization and limited financial resources.
- Dependence on the Tapout brand and WWE partnership.
- Negative P/E ratio indicates current lack of profitability.
- Limited number of employees (4) may constrain operational capacity.
Catalysts
- Upcoming: Potential expansion of the Tapout product line with new nutraceutical formulations in Q3 2026.
- Ongoing: Continued marketing and sales efforts through the WWE partnership.
- Upcoming: Possible strategic partnerships with other healthcare companies by Q4 2026.
- Ongoing: E-commerce expansion to increase online sales and reach a wider customer base.
- Upcoming: Potential for new product development and innovation in the healthcare sector by 2027.
Risks
- Potential: Competition from larger, more established players in the healthcare and nutraceutical markets.
- Potential: Changes in consumer preferences and demand for healthcare products.
- Ongoing: Regulatory challenges and compliance requirements in the healthcare industry.
- Potential: Loss of the Tapout license or termination of the WWE partnership.
- Ongoing: Limited financial resources and small market capitalization.
Growth Opportunities
- Expansion of Tapout Product Line: Allstar Health Brands, Inc. has the opportunity to expand its Tapout product line to include new nutraceutical products and formulations. The global nutraceutical market is projected to reach $500 billion by 2028, driven by increasing consumer awareness of health and wellness. By introducing innovative Tapout products, Allstar can capitalize on this growing market and increase its revenue. This expansion could occur within the next 1-3 years, depending on product development and regulatory approvals.
- Geographic Expansion: Allstar Health Brands, Inc. can expand its geographic reach beyond the Americas to target new markets in Europe and Asia. The global healthcare market is experiencing growth in emerging economies, driven by increasing healthcare spending and aging populations. By entering these markets, Allstar can diversify its revenue streams and reduce its reliance on the Americas. This expansion could occur within the next 3-5 years, depending on market entry strategies and regulatory approvals.
- Strategic Partnerships: Allstar Health Brands, Inc. can pursue strategic partnerships with other companies in the healthcare and wellness industry to expand its product offerings and distribution channels. By partnering with established players, Allstar can gain access to new markets and technologies, as well as increase its brand awareness. These partnerships could be formed within the next 1-2 years, depending on negotiation and due diligence processes.
- E-commerce Expansion: Allstar Health Brands, Inc. can expand its e-commerce presence to reach a wider customer base and increase its online sales. The e-commerce market is experiencing rapid growth, driven by increasing internet penetration and changing consumer behavior. By investing in its e-commerce platform and digital marketing efforts, Allstar can capitalize on this trend and increase its revenue. This expansion could occur within the next 6-12 months, depending on website development and marketing strategies.
- New Product Development: Allstar Health Brands, Inc. can invest in research and development to create new and innovative healthcare products that address unmet needs in the market. By developing proprietary formulations and technologies, Allstar can differentiate itself from its competitors and create a sustainable competitive advantage. This development could take 2-5 years, depending on the complexity of the products and regulatory approvals.
Opportunities
- Expansion of the Tapout product line to include new nutraceutical formulations.
- Geographic expansion into new markets beyond the Americas.
- Strategic partnerships with other companies in the healthcare and wellness industry.
- Increased focus on e-commerce and digital marketing to reach a wider customer base.
Threats
- Competition from larger, more established players in the healthcare and nutraceutical markets.
- Changes in consumer preferences and demand for healthcare products.
- Regulatory challenges and compliance requirements in the healthcare industry.
- Potential loss of the Tapout license or termination of the WWE partnership.
Competitive Advantages
- Tapout Brand License: Exclusive rights to market and sell Tapout-branded nutraceutical products provide a competitive advantage.
- WWE Partnership: Collaboration with WWE expands brand reach and market access.
- Specialty Healthcare Focus: Niche focus allows for specialized product development and marketing efforts.
About ALST
Founded in 1997 and headquartered in Toronto, Canada, Allstar Health Brands, Inc. operates as a specialty healthcare products company. Originally named Axxess Pharma, Inc., the company rebranded in June 2017 to reflect its evolving focus on enhancing health and quality of life through a range of healthcare products. Allstar Health Brands focuses on select medicines, natural nutritional supplements, and over-the-counter remedies in the Americas. A key aspect of Allstar's business is its exclusive license to market and sell Tapout-branded nutraceutical products globally, including pain relief sprays and wipes. This licensing agreement allows Allstar to leverage the established Tapout brand, particularly within the fitness and sports market. The company also has a partnership with World Wide Entertainment (WWE) to market and sell their line of Tapout nutraceutical products, further expanding its reach and brand recognition within the health and wellness sector.
What They Do
- Develops and markets specialty healthcare products.
- Offers select medicines, natural nutritional supplements, and over-the-counter remedies.
- Holds the Tapout license to sell globally branded nutraceutical products.
- Markets and sells pain relief sprays and wipes under the Tapout brand.
- Partners with World Wide Entertainment (WWE) to market and sell Tapout nutraceutical products.
- Focuses on enhancing health and quality of life for consumers in the Americas.
Business Model
- Develops and markets healthcare products, including medicines, supplements, and over-the-counter remedies.
- Generates revenue through the sale of Tapout-branded nutraceutical products under a licensing agreement.
- Utilizes a partnership with WWE to expand the reach and brand recognition of Tapout products.
Industry Context
Allstar Health Brands, Inc. operates within the competitive medical-pharmaceuticals industry. This sector is characterized by stringent regulatory requirements, rapid technological advancements, and evolving consumer preferences. Companies in this industry face challenges related to product development, marketing, and distribution. The nutraceutical market, in particular, is experiencing growth driven by increasing consumer awareness of health and wellness. Allstar's partnership with WWE and the Tapout license provide a unique position within this market, but the company faces competition from larger, more established players.
Key Customers
- Consumers seeking select medicines, natural nutritional supplements, and over-the-counter remedies.
- Athletes and fitness enthusiasts interested in Tapout-branded nutraceutical products.
- WWE fans who purchase Tapout products through the partnership with World Wide Entertainment.
Financials
Chart & Info
Allstar Health Brands, Inc. (ALST) stock price: Price data unavailable
Latest News
-
Allstar Health Brands (OTCMKTS:ALST) Stock Price Crosses Above Fifty Day Moving Average – What’s Next?
defenseworld.net · Mar 19, 2026
-
ALST Announces Formal Offer to Acquire 55% Stake in Imperia Calcio
feeds.newsfilecorp.com · Mar 17, 2026
-
Allstar Health Brands (OTCMKTS:ALST) Stock Price Crosses Above 50-Day Moving Average – What’s Next?
defenseworld.net · Mar 11, 2026
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ALST.
Price Targets
Wall Street price target analysis for ALST.
MoonshotScore
What does this score mean?
The MoonshotScore rates ALST's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Allstar Health Brands (OTCMKTS:ALST) Stock Price Crosses Above Fifty Day Moving Average – What’s Next?
ALST Announces Formal Offer to Acquire 55% Stake in Imperia Calcio
Allstar Health Brands (OTCMKTS:ALST) Stock Price Crosses Above 50-Day Moving Average – What’s Next?
Stocks That Hit 52-Week Lows On Tuesday
Leadership: Peter Daniel Bagi
CEO
Peter Daniel Bagi is the CEO of Allstar Health Brands, Inc. He is responsible for managing the company's overall strategy and operations. His background includes experience in the healthcare and pharmaceutical industries. He oversees a small team of 4 employees, focusing on the development and marketing of specialty healthcare products. His leadership is crucial for navigating the competitive landscape and achieving the company's growth objectives.
Track Record: Under Peter Daniel Bagi's leadership, Allstar Health Brands, Inc. has focused on expanding its Tapout product line and leveraging its partnership with WWE. Key milestones include maintaining the Tapout license and navigating the challenges of the OTC market. His strategic decisions aim to enhance the company's market position and drive revenue growth. However, the company's financial performance remains a key area of focus.
ALST OTC Market Information
The OTC Other tier, where Allstar Health Brands, Inc. trades, represents the lowest tier of the OTC market. Companies in this tier often have limited financial disclosure and may not meet minimum listing requirements. This tier is distinct from exchanges like the NYSE or NASDAQ, which have stricter listing standards, including minimum share price, market capitalization, and financial reporting requirements. Investing in companies on the OTC Other tier carries higher risks due to the lack of regulatory oversight and potential for limited liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: Lack of transparency in financial reporting increases investment risk.
- Illiquidity: Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
- Regulatory Scrutiny: OTC stocks are subject to less regulatory oversight than exchange-listed stocks.
- Potential for Fraud: Higher risk of fraudulent activity due to limited oversight.
- Price Volatility: OTC stocks can experience significant price swings due to low trading volume and speculative trading.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the company's capital structure and ownership.
- Check for any regulatory actions or legal proceedings.
- Consult with a financial advisor before investing.
- Tapout Brand License: Holding the Tapout license suggests a degree of legitimacy and brand recognition.
- WWE Partnership: Collaboration with WWE indicates a level of business credibility.
- Operational History: The company has been in operation since 1997, suggesting some stability.
- Headquarters in Canada: Being based in Canada may provide some level of regulatory oversight and corporate governance.
Common Questions About ALST
What does Allstar Health Brands, Inc. do?
Allstar Health Brands, Inc. is a specialty healthcare products company that focuses on enhancing health and quality of life by offering select medicines, natural nutritional supplements, and over-the-counter remedies in the Americas. A key component of their business is holding the Tapout license, which allows them to sell globally branded nutraceutical products, including pain relief sprays and wipes. They also have a partnership with World Wide Entertainment (WWE) to market and sell their line of Tapout nutraceutical products, leveraging the brand recognition of both Tapout and WWE to reach a broader consumer base.
What do analysts say about ALST stock?
Currently, there is no available analyst coverage for Allstar Health Brands, Inc. (ALST). The company's small market capitalization and OTC listing may contribute to the lack of analyst coverage. Investors should conduct their own due diligence and carefully consider the company's financial performance, competitive landscape, and regulatory environment before making investment decisions. Key valuation metrics, such as revenue growth, profitability, and cash flow, should be closely monitored to assess the company's potential for future growth.
What are the main risks for ALST?
Allstar Health Brands, Inc. faces several risks, including competition from larger, more established players in the healthcare and nutraceutical markets. The company's dependence on the Tapout brand and WWE partnership also poses a risk, as any changes to these agreements could negatively impact its revenue. Regulatory challenges and compliance requirements in the healthcare industry are ongoing concerns. Additionally, the company's limited financial resources and small market capitalization increase its vulnerability to market fluctuations and economic downturns. The OTC listing adds further risks related to liquidity and regulatory oversight.
What are the key factors to evaluate for ALST?
Evaluating ALST involves reviewing fundamentals, analyst consensus, and risk factors. Key strength: Tapout brand license provides a recognizable brand in the nutraceutical market.. Primary risk to monitor: Potential: Competition from larger, more established players in the healthcare and nutraceutical markets.. This is not financial advice.
How frequently does ALST data refresh on this page?
ALST prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ALST's recent stock price performance?
Recent price movement in Allstar Health Brands, Inc. (ALST) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Tapout brand license provides a recognizable brand in the nutraceutical market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ALST overvalued or undervalued right now?
Determining whether Allstar Health Brands, Inc. (ALST) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ALST?
Before investing in Allstar Health Brands, Inc. (ALST), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- OTC market data may be less reliable than exchange-listed data.
- AI analysis is pending and may provide additional insights.